Marco Lanza

Title: Marco Lanza: Innovator in Pharmaceutical Chemistry

Introduction

Marco Lanza is a notable inventor based in Lecco, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new compounds for treating various medical conditions. With a total of 2 patents, Lanza's work focuses on innovative solutions for complex health issues.

Latest Patents

Lanza's latest patents include the development of 6-1H-imidazo-quinazoline and quinolines derivatives, which serve as new Monoamine Oxidase (MAO) inhibitors and imidazoline receptor ligands. These compounds are designed to act as effective treatments for depression, Parkinson's disease, drug abuse, and morphine tolerance and dependence. Additionally, he has worked on 2-aryl and 2-heteroaryl 4H-1-benzopyran-4-one-6-amidino derivatives, which are promising pharmacological agents for the treatment of arthritis, cancer, and related pain.

Career Highlights

Marco Lanza is currently employed at Rottapharm Spa, where he continues to innovate in the pharmaceutical sector. His research has led to the creation of compounds that have the potential to significantly improve patient outcomes in various therapeutic areas.

Collaborations

Lanza collaborates with esteemed colleagues such as Antonio Giordani and Gianfranco Caselli, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Marco Lanza's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to addressing critical health challenges through scientific advancement.